← SynDRA
LUTEOLIN
SynDRA canonical compound SYN0001845 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | AKR1B1 | GAA | MAOA | TOP1 | XDH |
|---|
| Mechanism of action | glucosidase inhibitor |
|---|
All known targets
- TOP1
- AKR1B1
- Bact vanYB
- GAA
- LPCAT1
- LPCAT2
- MAOA
- TAS2R14
- TAS2R39
- XDH
Mechanisms of action (all sources)
- TAS2R14 AGONIST
- TAS2R39 AGONIST
- glucosidase inhibitor
- Bact vanYB INHIBITOR
- TOP1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB1
- PIN1
- NR1H3
- NR3C1
- PARP1
- PBRM1
- PDK1
- PIM1
- PKMYT1
- KDM4A
- PLG
- PNLIP
- POLB
- POLH
- POLI
- POLK
- NR1H2
- NOX4
- NFE2L2
- MMP9
- MMP7
- MMP3
- MMP2
- MMP13
- MMP12
- MMP1
- MKNK2
- MKNK1
- MBNL1
- MAPT
- MAOB
- LMNA
- LCK
- PON1
- PSMB5
- PTGS1
- SYK
- WRN
- USP1
- TYR
Cross-references
Synonyms
- Cyanidenon-1470
- Digitoflavone
- Flacitran
- Luteoline
- Luteolol
- Salifazide
- Weld lake
- Yama kariyasu
- B-Lactams
- 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
- Weld Lake
- Cyanidenon 1470
- 5,7,3',4'-Tetrahydroxyflavone
- UNII-KUX1ZNC9J2
- CI Natural Yellow 2
- 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
- 7-Tetrahydroxyflavone
- CCRIS 3790
- EINECS 207-741-0
- KUX1ZNC9J2
- CHEMBL151
- BRN 0292084
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
- 3',4',5,7-Tetrahydroxyflavone
- 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone
- CHEBI:15864
- 3',4',5,7-Tetrahydroxy-Flavone
- RefChem:6458
- DTXCID6040668
- Bismite
- Luteolin (Standard)
- MFCD00017309
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one
- FLAVONE, 3',4',5,7-TETRAHYDROXY-
- C.I. Natural Yellow 2
- SMR000326896
- SR-01000779333
Look up LUTEOLIN in the interactive SynDRA portal →